Addressing The Challenges And Opportunities In Gynecologic Cancer Research

Despite the impact on women’s health worldwide, significant unmet needs exist in the diagnosis and treatment of gynecologic cancers. Located in the female reproductive system, many have a reputation for being “silent,” as they are often detected in later stages when treatment options are limited.

However, the recent introduction of novel medicines — targeted therapies in particular — has led to improvements in patient care and uncovered new research opportunities, creating a competitive research environment. With investment in research on the rise, investigators face challenges in patient identification, site selection and an ever-changing regulatory landscape.

Join Premier Research experts, (Moderator) Mary Gunn, PhD, COO, Women’s Health and Diagnostics; Rupa Doshi, PhD, Vice President, Program Strategy, Oncology; Andrew Berchuck, MD, Medical Advisor, Gynecologic Oncology; and Irene Figari, Senior Director, Regulatory Affairs, Premier Consulting.